-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

114.O2.6 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Therapeutic Advances in Sickle Cell Disease

Symposia: Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, Adult, Clinical trials, Combination therapy, Translational Research, Epidemiology, Drug development, Clinical Research, Health outcomes research, Hemoglobinopathies, Health disparities research, Pediatric, Hematopoiesis, Diseases, Patient-reported outcomes, Treatment Considerations, Non-Biological therapies, Adverse Events, Metabolism, Young adult , Biological Processes, Surgical, Technology and Procedures, Study Population, Human, Machine learning
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Hall B (San Diego Convention Center)
Moderators:
Shaniqua Johnson Anum, MD, ARRAY(0xf1ab710) and Oladipo Cole, MD, MBA, University of Connecticut
Disclosures:
Cole: Novo Nordisk: Consultancy, Honoraria; Agios: Honoraria.
This session is about sickle cell research that encompasses the globe and research that focuses on sickle cell care across the lifetime of the individuals living with Sickle Cell Disease.
2:00 PM

Abena Appiah-Kubi, MD, MPH1, Seethal A Jacob, MD, MS2,3, Matthew M. Heeney, MD4, Connie M. Piccone, MD5, Omar Niss, MD6, Charles T. Quinn, MD, MS7, Stephanie A. Fritch Lilla, MD8, Maa-Ohui Quarmyne, MD, MS9, Angeli Rampersad, MD10*, Allison Remiker, MD11*, Amy Tang, MD12, Min Dong, PhD13*, Kathryn McElhinney, BS14*, Joshua R. Tanzer, PhD15* and Patrick T. McGann, MD, PhD16,17

1Cohen Children's Medical Center, Northwell Health, New Hyde Park, NY
2Department of Pediatrics, Division of Children’s Health Services Research, Indiana University School of Medicine, Indianapolis, IN
3Department of Pediatrics, Division of Pediatric Hematology, Oncology, and Stem Cell Transplant, Riley Hospital For Children, Indianapolis, IN
4Dana–Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
5Carle Foundation Hospital, Urbana, IL
6Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
7Division of Hematology, Cincinnati Children's Hospital Med. Ctr., Cincinnati, OH
8Children's Minnesota, Minneapolis, MN
9Center of Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ
10Indiana Hemophilia and Thrombosis Center, Indianapolis, IN
11Medical College of Wisconsin, Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, Pewaukee, WI
12Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
13Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
14Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
15Lifespan Biostatistics, Epidemiology, and Research Design, Providence, RI
16Brown University Health Sickle Cell Center, Providence, RI
17The Warren Alpert Medical School of Brown University, Providence, RI

2:15 PM

Josu de la Fuente, PhD FRCP1,2, Jacques-Emanuel Galimard3*, Arnaud Dalissier, BSc4*, Mohsen Al Zahrani5*, Ali Alahmari, MD6*, Fahad Almohareb6, Jean-Hugues Dalle, MD, PHD7, Nathalie Dhédin, MD8*, Hakan Ozdogu, MD9*, Mohamed Salaheldin Bayoumy, MD10*, Marco Zecca, MD11*, Cristina Belendez, MD12*, Javid Gaziev, MD, PhD13*, Arjan C. Lankester, MD PhD14*, Philippe Lewalle Sr., MD15*, Gaurav Kharya, DCH, DNB, FIAP16*, Sarah Lawson17*, Bénédicte Neven18*, Sandrine Bremathas, RN19* and Emanuele Angelucci, MD20

1Department of Paediatrics, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
2Division of Immunology and Inflammation, Imperial College London, London, United Kingdom
3EBMT Paris Study Office, Paris, FRA
4EBMT Paris Study Unit, Saint Antoine Hospital, INSERM UMR-S 938, Sorbonne University, Paris, France
5Oncology department, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University of Health Sciences, Saudi society of bone marrow transplant, Riyadh, Saudi Arabia
6Department of Hematology, Stem Cell Transplantation, and Cellular Therapy, Cancer Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
7Department of Pediatric Hematology and Immunology, Robert-Debré Academic Hospital ,, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
8Service d'Hématologie Adolescents et Jeunes Adultes, Hôpital Saint-Louis, PARIS, France
9Baskent University Hospital, Adana, TUR
10King Faisal Specialist Hospital & Research Center, Jeddah, SAU
11Pediatric Hematology-Oncology,, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
12Pediatric Hemato-Oncology, Hospital Gregorio Marañón, IiSGregorio Marañón, CIBERER-ISCIII, ERN-EuroBloodNet, Faculty of Medicine, Universidad Complutense, Madrid, Spain., Madrid, Spain
13Mediterranean Institute of Hematology, Rome, ITA
14Division of Stem cell Transplantation, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands
15Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Hematology Department, Brussels, BEL
16Indraprastha Apollo Hospital, Delhi, India
17Birmingham Children`s Hospital, Birmingham, United Kingdom
18Unité d'Immuno-Hématologie et Rhumatologie Pédiatrique, Assistance Publique-Hôpitaux de Paris, Paris, France
19IMPERIAL COLLEGE HEALTHCARE NHS TRUST, London, United Kingdom
20Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, ITA

2:30 PM

Haiou Li1*, Vandana Sachdev, MD2*, Xin Tian, PhD3*, My-Le Nguyen, MD2*, Matthew Hsieh, MD4, Courtney D. Fitzhugh, MD4, Emily Limerick, MD4, Wynona Coles4*, Nancy Asomaning, MS5*, Anna Conrey, NP5*, Colin O. Wu, PhD6* and Swee Lay Thein, MBBS, DSc, FRCP, FRCPath, MRCP, MRCPath5

1Sickle Cell Branch, National Heart, Lung, and Blood Institute, NIH, Arlington, VA
2Echocardiography laboratory, National Heart, Lung and Blood Institutes, NIH, Bethesda, MD
3Office of Biostatistics Research, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
4Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
5Sickle Cell Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
6Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

2:45 PM

Titilope A Adeyemo, MBBS, MSc, FMCPath1*, Nelly Kiriza, MD, MPH2,3*, Feyisayo T. Oluwole, RN1*, Mark Jelinek, MS4*, Jude Jonassaint, RN2*, Olubusola Oluwole, MD, MS2,3, Christine Saber, MD2,3*, Brian J Philips, PhD3*, Olusegun-Joseph D Akinsanya, FMCP1*, Vincent O Osunkalu, FMCPath1*, Laura M. DeCastro, MD, MHSc2,3, Enrico M Novelli, MD, MS2,3 and Julia Z Xu, MD, MS2,3

1College of Medicine University of Lagos (CMUL), Lagos, Nigeria
2Division of Classical Hematology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
3Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
4Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA

3:00 PM

Sophia Delicou1*, Fuad El Rassi2*, Biree Andemariam, MD3, Miguel R. Abboud, MD4, Julie Kanter, MD5, Marilyn J. Telen, MD6, Jessie Githanga7*, Adlette Inati, MD8, Ibrahim Idris9, Sunil Navani10*, Eric Wu11* and Andrew Eisenberger12

1Hippokrateio General Hospital, Athens, Greece
2Emory University School of Medicine, Atlanta, GA
3University of Connecticut Health, Farmington, CT
4American University of Beirut, Beirut, Lebanon
5University of Alabama at Birmingham, Birmingham, AL
6Duke University Medical Center, Durham, NC
7University of Nairobi, Nairobi, Kenya
8Lebanese American University Gilbert and Rose-Marie Chagoury School of Medicine, Byblos and NINI Hospital, Tripoli, Lebanon
9Aminu Kano Teaching Hospital/Bayero University, Kano, Nigeria
10Novo Nordisk Ltd, Oxford, United Kingdom
11Novo Nordisk Inc., Lexington, KY
12Columbia University Irving Medical Center, New York, NY

3:15 PM

Matthew M. Heeney, MD1, David C Rees2, Slimane Allali3*, Isaac Odame, MBBCh4, Rodolfo D Cançado5*, Adlette Inati, MD6, Elena Cela, MD, PhD7*, Deborah Keefe8*, Evgeniya Reshetnyak8*, Velusamy Shanmuganathan Muthusamy9*, Lidiya Bebrevska10*, Michele L Nassin8 and Julie Kanter, MD11

1Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
2Department of Paediatric Haematology, King's College London, London, United Kingdom
3Department of Pediatrics and Sickle Cell Center APHP, Centre-Université Paris Cité, Necker Hospital for Sick Children, Laboratory of Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM U1163, Institut Imagine, Paris, France
4The Hospital for Sick Children (SickKids) and the University of Toronto, Toronto, ON, Canada
5Department of Oncology and Hematology, Hospital Samaritano de Sao Paulo, São Paulo, Brazil
6Lebanese American University Gilbert and Rose-Marie Chagoury School of Medicine, Byblos and NINI Hospital, Tripoli, Lebanon
7Pediatric Hematology and Oncology, Hospital Gregorio Marañón. Universidad Complutense de Madrid, Madrid, Spain
8Novartis Pharmaceuticals Corporation, East Hanover, NJ
9Novartis Healthcare Pvt. Ltd., Hyderabad, India
10Novartis Pharma AG, Basel, Switzerland
11University of Alabama at Birmingham, Birmingham, AL

*signifies non-member of ASH